Joint Formulary & PAD

Fluticasone with salmeterol (Seretide Accuhaler) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Fluticasone with salmeterol (Seretide Accuhaler)
Indication :
Asthma
Group Name :
ICS LABA
Keywords :
ICS LABAs, ICS/LABAs, inhaled corticosteroids, long-acting beta agonists, respiratory, asthmatics
Brand Names Include :
Seretide Accuhaler
Important Information :

Salmeterol containing preparations not recommended in asthma guideline.

Increased risk of adrenal suppression in children.

Not for initiation in new patients

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Fluticasone with salmeterol (Seretide Accuhaler) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (0)

  • No records returned.